Estrategia para el diagnóstico de las dislipidemias. Recomendación 2018

Revista del Laboratorio Clínico Pub Date : 2019-10-01 DOI:10.1016/j.labcli.2019.03.001

Beatriz Candás Estébanez , Miguel Pocoví Mieras , Carlos Romero Román , Juan Carlos Vella Ramírez , Margarita Esteban Salán , María José Castro Castro , Enrique Rodríguez García , Teresa Arrobas Velilla , Pilar Calmarza , José Puzo Foncillas

{"title":"Estrategia para el diagnóstico de las dislipidemias. Recomendación 2018","authors":"Beatriz Candás Estébanez , Miguel Pocoví Mieras , Carlos Romero Román , Juan Carlos Vella Ramírez , Margarita Esteban Salán , María José Castro Castro , Enrique Rodríguez García , Teresa Arrobas Velilla , Pilar Calmarza , José Puzo Foncillas","doi":"10.1016/j.labcli.2019.03.001","DOIUrl":null,"url":null,"abstract":"<div><p>Dyslipidaemias are alterations in lipid metabolism that involve an excess, as well as a deficit, in lipid concentrations. These alterations are strongly associated with atherosclerosis, and it has been shown that its control reduces the incidence of episodes of ischaemic origin. Diagnosing dyslipidaemias from an aetiological point of view is very important, since the cardiovascular risk to which each one predisposes is different, and depends on the type of lipoprotein that is altered and its concentration. For this reason, it is very useful to have simple diagnostic algorithms that include the measurements of lipid metabolism that are available in most clinical laboratories in order to make the initial diagnosis of the type of dyslipidaemia. In the case of having the right diagnostic tools, identify it; and if not, to have the appropriate information to recommend the extension of the study in another centre with resources to establish the diagnosis</p></div>","PeriodicalId":101105,"journal":{"name":"Revista del Laboratorio Clínico","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.labcli.2019.03.001","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista del Laboratorio Clínico","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1888400819300479","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

Abstract

Dyslipidaemias are alterations in lipid metabolism that involve an excess, as well as a deficit, in lipid concentrations. These alterations are strongly associated with atherosclerosis, and it has been shown that its control reduces the incidence of episodes of ischaemic origin. Diagnosing dyslipidaemias from an aetiological point of view is very important, since the cardiovascular risk to which each one predisposes is different, and depends on the type of lipoprotein that is altered and its concentration. For this reason, it is very useful to have simple diagnostic algorithms that include the measurements of lipid metabolism that are available in most clinical laboratories in order to make the initial diagnosis of the type of dyslipidaemia. In the case of having the right diagnostic tools, identify it; and if not, to have the appropriate information to recommend the extension of the study in another centre with resources to establish the diagnosis

查看原文本刊更多论文

血脂异常的诊断策略。建议2018年

血脂异常是脂质代谢的改变，包括脂质浓度的过量和不足。这些改变与动脉粥样硬化密切相关，研究表明，对其进行控制可降低缺血性发作的发生率。从病因学角度诊断血脂异常是非常重要的，因为每个人易患的心血管风险是不同的，这取决于被改变的脂蛋白的类型及其浓度。由于这个原因，拥有简单的诊断算法是非常有用的，包括在大多数临床实验室中可用的脂质代谢测量，以便对血脂异常的类型进行初步诊断。在拥有正确诊断工具的情况下，识别它;如果没有，有适当的信息，建议在另一个有资源的中心进行研究，以确定诊断

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista del Laboratorio Clínico

自引率

0.00%

发文量